NeuroLight Appoints Geoffrey Lawrence as Chief Financial Officer
tbarthel
A seasoned finance leader to spearhead capital strategy as company advances non-pharmacological sleep technology
Helping people achieve optimal brain states — on-demand.
NeuroLight offers a groundbreaking approach to neuromodulation and brain entrainment to improve sleep and achieve optimal brain states. Building on Crick and Koch’s hypothesis that “every mental state is expressed in neural correlates,” we further hypothesized that inducing brain states’ neural correlates can induce the desired mental state. To this end, we record brainwave activity that occurs during a desired state, and induce this activity in another (or the same subject at a different time) to replicate the desired mental state. We do this via neuromodulation using light and sound.
With this technology and approach, we envision a world where anyone can realize desired brain states on-demand in order to improve their health and optimize performance.
Founder & CEO
Alex Poltorak is a scientist, serial inventor, founder, and entrepreneur with multiple exits via acquisition and IPO. He was trained as a theoretical physicist, and has had professorships at Cornell University Medical College, Touro College, and the City College of New York (CUNY). His journey in neuroscience began when he served as the assistant professor of biomathematics at the neurology departments of Cornell University Medical College. He is now focusing on brain research in general and neuromodulation in particular
20 years in neuroscience and sleep research in academia and industry
Dr. Goldberg has over 18 years of leadership experience advancing innovative neuroscience technologies to market.
Geoffrey Lawrence is a seasoned financial executive with extensive experience leading companies in highly regulated industries, particularly therapeutic and medical product development and distribution.
M.S. in Biomedical Engineering and over 12 years of experience in securing non-dilutive funding for healthcare and biotech companies.
Dr. Buff has over 20 years experience in innovation management, technology transfer, IP licensing, and business development.
Healthcare senior executive, MedTech/ medical device startup advisor and investor, and former division president at Thermo Fisher Scientific
Former Chief Scientist of the US Army Research Laboratory (ARL), And DARPA Program Manager
Chief Technical Officer for multiple successful MedTech companies, leading the development of FDA-approved devices in neuromodulation
A physician with 17-year tenure as a NASA Mission Specialist Astronaut, and Spacewalker and 14 years in C-suite and Board-level positions
Professor Emeritus of Cellular & Molecular Pharmacology in the School of Medicine, University of California, San Francisco
A seasoned finance leader to spearhead capital strategy as company advances non-pharmacological sleep technology
Strategic Biotech/MedTech Leader Brings 18 Years of Neuroscience Innovation Experience to Revolutionary Neuromodulation Platform.
NeuroLight, Inc. is pleased to announce the appointment of Kai Peterson as our new Director of Non-dilutive Funding and Grants.
NeuroLight, Inc. is pleased to announce the appointment of Kai Peterson as our new Director of Non-dilutive Funding and Grants.
Pomona, New York — April 2025 — NeuroLight, Inc. is pleased to announce the successful presentation of its latest research at the Annual Advances in
Pomona, New York — February 19, 2025 — NeuroLight, Inc., a pioneering neuromodulation medical device company, today announced the appointment of Jeffry B. Lansman, Ph.D.